相关实验视频
Updated: Jun 8, 2025

04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
5.6K
阿齐思罗米用于预防极度早产婴儿的支气管肺形:一项队列研究
Yali Zeng1, Zhifeng Huang1, Yanqiong Wang1
1Department of Neonatology, Shenzhen Maternity and Child Healthcare Hospital, the First School of Medicine, Southern Medical University, Shenzhen, China.
Pediatric pulmonology
|November 6, 2024
概括
阿齐思罗米显著降低了无肺感染的极度早产婴儿 (EPI) 发生支气管肺功能失调 (BPD) 的风险. 这一发现表明,阿齐思罗米在预防这种脆弱人群中BPD的潜在益处.
科学领域:
- 新生儿医学 新生儿医学
- 儿科肺病学 儿科肺病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 支气管肺功能障碍症 (BPD) 是极度早产婴儿 (EPI) 的一个重大并发症.
- 乌雷亚等离子体物种的殖民是EPI中BPD的已知危险因素.
- 阿齐思罗米在预防BPD中的预防性或治疗性作用仍然是研究领域.
研究的目的:
- 评估阿齐思罗米对EPI中II级或更高BPD发生率的影响.
- 为了确定阿齐思罗米辛治疗,特别是Ureaplasma物种的殖民,是否与没有其他肺部感染的EPI中BPD风险降低有关.
主要方法:
- 从2018年9月到2022年9月,对237个EPI进行了回顾性队列研究.
- 婴儿被分为两组:阿兹罗米辛治疗 (Ureaplasma 种植) 和没有阿兹罗米辛治疗 (Ureaplasma 种消极).
- 使用后勤回归分析来评估阿兹罗米辛治疗与II级+BPD之间的关联,并对潜在的混因素进行调整.
主要成果:
- 阿兹罗米辛治疗与II级+ BPD的发生率显著降低 (8.6%与31.2%,p=0.006).
- 接受阿齐思罗米的婴儿在侵入性通风的持续时间也较短 (0对3天,p=0.045).
- 经调整后的分析证实,在整个队列和没有其他肺部感染的婴儿中,阿兹罗密辛治疗与减少BPD风险 (OR 0.211) 有显著的关联 (OR 0.115).
结论:
- 阿齐思罗米的使用与极度早产婴儿II级+BPD发育的风险降低有关.
- 阿齐思罗米的抗炎性质可能有助于其对BPD的保护作用.
- 这些发现支持考虑阿齐思罗米用于Ureaplasma殖民的EPI,以潜在地预防BPD.
相关概念视频
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
233
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
233
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Breathing
58.6K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
58.6K
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120

